Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
de Wit, K, Schaapman, J J, Nevens, F, Verbeek, J, Coenen, S, Cuperus, F J C, Kramer, M, Tjwa, E T T L, Mostafavi, N, Dijkgraaf, M G W, van Delden, O M, Beuers, U H W, Coenraad, M J, Takkenberg, R B
Published in BMJ open gastroenterology (28.12.2020)
Published in BMJ open gastroenterology (28.12.2020)
Get full text
Journal Article
Pharmacological therapies for unconjugated hyperbilirubinemia
Cuperus, F J C, Hafkamp, A M, Hulzebos, C V, Verkade, H J
Published in Current pharmaceutical design (01.09.2009)
Published in Current pharmaceutical design (01.09.2009)
Get more information
Journal Article